Sculptor Capital’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Sculptor Capital’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-39,700	Closed	-$2.98M	–	403
2020 Q2	$2.98M	Buy	+39,700	New	+$2.08M	0.03%	172
2020 Q1	–	Sell	-46,600	Closed	-$1.17M	–	330
2019 Q4	$1.17M	Buy	+46,600	New	+$1.11M	0.01%	202

Other funds holding LVGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sculptor Capital's LVGO Position: Q3 2020 in Review

Sculptor Capital sold out of Livongo Health, Inc. Common Stock (LVGO) in Q3 2020, closing a stake of 39,700 shares — an estimated $2.98M sold.

Sculptor Capital first reported a position in LVGO in Q4 2019 and held it in 2 quarters. The position peaked at $2.98M in Q2 2020. 391 funds tracked by Wall St. Rank hold LVGO as of Q3 2020.

Sculptor Capital reported no remaining Livongo Health, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Sculptor Capital sold 39,700 Livongo Health, Inc. Common Stock shares in Q3 2020, an estimated $2.98M.
Sculptor Capital first reported a position in Livongo Health, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Sculptor Capital's Livongo Health, Inc. Common Stock position peaked at $2.98M in Q2 2020.
391 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q3 2020.

Based on Sculptor Capital's 13F filing for Q3 2020, filed 12 Nov 2020.